Partner Content Partner Content Spotlight sessions at the upcoming Lyophilization USA Confer... Lyophilization USA Conference
Partner Content Partner Content Achieving Controlled Nucleation During Aseptic Lyophilizatio... 4th Annual Lyophilization USA Conference
News Ipsen licenses Simcere ADC in $1bn-plus deal Deal-hungry Ipsen is at it again, pledging around $1bn for rights to an antibody-drug conjugate (ADC) for cancer developed by China's Simcere.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
